key: cord-0010248-s0cvc1q5 authors: Tan, Shawn Zheng Kai; Tan, Mark Zheng Yi; Prabakaran, Mookkan title: Saffold virus, an emerging human cardiovirus date: 2016-10-10 journal: Rev Med Virol DOI: 10.1002/rmv.1908 sha: 953c601ac5bef62d025d2c4f98e6c6a86d9cf749 doc_id: 10248 cord_uid: s0cvc1q5 Saffold virus (SAFV) is an emerging human cardiovirus that has been shown to be ubiquitous. Initial studies of SAFV focused on respiratory and gastrointestinal infection; however, it has also recently been associated with diverse clinical symptoms including the endocrine, cardiovascular, and neurological systems. Given the systemic nature of SAFV, and its high prevalence, understanding its pathogenicity and clinical impact is of utmost importance. This comprehensive review highlights and discusses recent developments in epidemiology, human pathogenicity, animal, and molecular studies related to SAFV. It also provides detailed insights into the neuropathogenicity of SAFV. We argue that human studies have been confounded by coinfections and therefore require support from robust molecular and animal research. Thereby, we aim to provide foresight into further research to better understand this emerging virus. Members of the cardiovirus genus of Picornaviridae are single-stranded RNA viruses, which were previously thought to mainly infect rodents. 1, 2 In 2007, however, a novel human cardiovirus was identified through sequence-independent genomic amplification from a historical stool sample of an 8-month-old child with fever of unknown origin. 3 This virus was designated Saffold virus (SAFV) after the lead author of the research, Morris Saffold Jones. Phylogenetic analysis revealed that SAFV is closely related to the theilovirus species, which consists of Theiler's murine encephalomyelitis virus (TMEV), Theiler's rat virus, and Vilyuisk human encephalomyelitis virus. 4 Since then, SAFV has been isolated from nasal and stool specimens of children with respiratory and gastrointestinal symptoms in many countries. 3, [5] [6] [7] [8] [9] [10] To date, 11 genotypes of SAFV have been identified on the basis of phylogenetic analysis of the VP1 gene 2 with SAFV-2 and SAFV-3 having high seroprevalence. 6, 11 Initial work with SAFV was hindered by poor growth in laboratory cell lines. 9, 12, 13 Subsequently, it was discovered that selected cell lines were indeed able to support the growth of SAFV (dependent on strain) thus the exponential increase in research data in recent years. 11 These cell lines include Vero, HeLa, NIH/3 T3, CHO-K1, Hep-2, and Neuro2A. 7, [13] [14] [15] [16] [17] Small studies demonstrating the role of SAFV in severe neurological deficits and death in children 6, 11, 18 has garnered the attention of the research community. In this review, we highlight recent advances in SAFV research, with a focus on CNS infection. Saffold virus is a non-enveloped single-stranded RNA virus, with an icosahedral capsid of approximately 30 nm in diameter. 7 The RNA genome is approximately 8050 nucleotides consisting of a single polyprotein coding region flanked by 2 UTRs at the 5' and 3' ends, with a variable length of poly (A) tail located at the terminus of the 3' Untranslated region (UTR). The polyprotein region is divided into the leader (L) protein, the precursor P1, which encodes capsid proteins (VP1 to VP4), and precursors P2 and P3 regions, which encode 7 nonstructural proteins (2A-2C and 3A-3D) 3 ( Figure 1A ). Similar to known picornaviruses, SAFV has a 5' UTR of about 1040 nucleotides, containing internal ribosome entry sites that enable the initiation of translation through binding of canonical initiation factors and internal ribosome entry site-specific trans-acting factors. 19, 20 The L protein located at the N-terminal portion of the polyprotein is thought to be highly important in the pathogenesis of the virus. The TMEV, a virus that is structurally and functionally similar to SAFV, 21 has been extensively studied because of its unusual phenotype. 2 TMEV is divided into † Authors contributed equally Abbreviations Used: CSF, Cerebrospinal fluid; HFMD, hand-foot-mouth disease; MS, multiple sclerosis; PIV, parainfluenza virus; SAFV, Saffold virus; TMEV, Theiler's murine encephalomyelitis virus; UTR, Untranslated region 2 subgroups on the basis of their neurovirulence 22 ; highly virulent strains (GDVII and FA) that cause acute fatal encephalomyelitis, and low virulent strains (DA and BeAn), which cause milder encephalomyelitis with chronic progression to a demyelinating syndrome similar to multiple sclerosis (MS). 2, 23 The L protein of TMEV has been shown to play an essential role in the differences seen between the 2 TMEV subgroups. 24 The typical characteristics of the L region of TMEV, and indeed other similar cardioviruses, contain a well-conserved zinc-finger motif, an acidic region and a serine/threonine-rich domain. 25 Interestingly, the serine/threonine-rich domain of L protein is partially deleted in SAFV. 7 On analysis, the homology of L between SAFV and TMEV DA strains is 78%. 16 In certain strains of TMEV (such as the DA strain), an alternative translation initiation site downstream from authentic initiation site is able to synthesize a small out-of-frame 18-kDa protein referred to as L*. 26 The SAFV lacks the AUG initiation codon required to translate L* protein, although it is unclear if the ACG present in that region of SAFV is used to produce a truncated L* protein. 2 While the capsid proteins of SAFV have not been studied directly, we are able to deduce some of its features from related cardioviruses like TMEV. The capsid proteins VP1 to VP3 are exposed on the external surface of the virion and are responsible for the initiation of infection by host-receptor bindings. The VP1 is the most exposed immunodominant protein and the most surface-accessible capsid protein. The EF and CD loop structures are located in the VP2 and VP1 proteins, respectively, and are associated with host cell tropism and pathogenesis in cardioviruses. 27, 28 The CD and EF loops are unique for each genotype of SAFV and are highly divergent among cardioviruses. Importantly, in addition to L protein, the CD loop of VP1 and the EF loop of VP2 have also been found to be important in virus persistence and host demyelination in TMEV. 28, 29 We have previously suggested these are potential areas of study regarding SAFV. 16 Reverse genetics has led to important advances in the understanding of the roles of both capsid and nonstructural proteins; the generation of infectious SAFV cDNA has allowed us to specifically modify the virus. 16, 30 Previously, Himeda et al 30 Figure 1B ). 16 In this method, the genomic viral cDNA is transcribed into an exact SAFV-like RNA by hpol1 inside the cells. Compared to T7 polymerase-driven reverse genetics systems, our approach has eliminated the need for troublesome in vitro RNA transcription from cDNA clones. It also eliminates the need to add extra bases during in vivo transcription at the 5' and 3' ends of viral transcripts. 32 Overall, studies using chimeric SAFV containing TMEV L have shown that the L protein is at least partially responsible for differences in suppression of interferons, cell tropism, pathogenicity of the virus, and nucleocytoplasmic trafficking. 16, 31, 33 The SAFV has been detected in patients globally [5] [6] [7] [9] [10] [11] [12] 17, 18, 21, [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] (see Table 1 in a 2-year-old child after hand-foot-mouth disease (HFMD). However, this patient was also known to have Kawasaki disease, from which pancreatitis is an uncommon but recognized complication (presumed to be from infiltration of autoimmune and inflammatory cells). 53 The SAFV has been isolated from nasopharyngeal aspirates of 0.2% to 24% of children suffering from nonspecific respiratory tract symptoms. 5, 10, 11, 17, 21, 36, 39, 40, 45, 47 Itagaki et al 39 pneumoniae, 36 respiratory syncytial virus, 36 and enterovirus. 36 The detection of coinfecting organisms is significant. This is especially prominent in the aforementioned studies and some others below investigating neurological symptoms. It may point to SAFV requiring the presence of coexisting infection to thrive, or coinfection may result in increased severity requiring presentation to medical institutions. Moreover, it clouds conclusions about primary organs of infection and the severity to which they are affected by SAFV. This is particularly the case with enteroviruses and mycoplasma pneumoniae, which have similar clinical manifestations to SAFV infection. 54, 55 Enteroviruses may cause a plethora of symptoms, which include upper respiratory tract symptoms, myocarditis, aseptic meningitis, HFMD, polio-like paralysis, make the significance of coinfection with SAFV very difficult to interpret. This may also act as a strong confounder in some studies discussed here. 11, 36, 47, 52 Likewise with mycoplasma pneumoniae, which may demonstrate Clinicians will note that the known symptoms of SAFV is not unlike other known and coinfected pathogens such as enterovirus, 55 norovirus, 56 rotavirus, 57 and mycoplasma pneumoniae. 54 The mainstay of treatment of most viral infections tends to be supportive. Therefore, our current understanding of SAFV does not affect patient care. This may perhaps change when primer and polymerase chain reactionbased methods of identifying pathogens in patients become more widely used and readily available in a variety of health care settings. [58] [59] [60] The current human studies discussed highlight the important systemic involvement of SAFV and give direction to further research in this area. However, a more cohesive understanding of human pathogenesis and symptoms is needed for translational therapeutic research to begin to tackle the health burden of SAFV. For a start, due to low detection rates of current infection, large sample sizes over many countries are needed to determine SAFV's true epidemiology. Moreover, meticulous data on SAFV-only infections is needed to elicit its true symptoms and route of spread, followed by targeted coinfection studies to establish its role in overall disease process. All these must be supported by a strong molecular and animal base of research. Although While studies on animal models of SAFV have focused on CNS infection, SAFV has also been found in other organs/tissues such as the heart, spleen, muscles, and pancreas ( Figure 2 ). 61 The L protein of TMEV has been shown to play an essential role in the establishment of persistent CNS infections in mice and therefore progression to demyelination. 24 The native truncated L protein of SAFV may be a possible reason for the lack of demyelination in SAFV infection. We hence generated a chimeric SAFV with the L protein of TMEV DA strain (which causes demyelination). 16 Initial results looked promising as the chimeric SAFV was able to infect macrophages. This is important as virus persistence in monocytes/macrophages is essential in TMEV induced demyelination. 74, 75 However, the low infection rate of macrophages suggests that apart from L*, additional factors are required for virulence. Importantly, the structural capsid proteins of TMEV, which has been shown to be important for receptor binding, 76 are completely different from that of SAFV and could explain the reason for low infectivity rates of macrophages. This low infectivity of macrophages is a potential reason for the lack of persistence despite the presence of TMEV DA L, 16 as persistent TMEV DA infection is thought to be a result of infected macrophages crossing the blood-brain barrier. 77 However, it should be noted that the activation or differentiation state of macrophages have been suggested to play an important role in TMEV infection 78 It may be easy to neglect SAFV given its low rate of debilitating infection in humans and low likelihood of progression to demyelinating FIGURE 2 Summary of animal studies done of Saffold virus. Diagram shows locations in which SAFV have been reported to be detected in mice models. This includes the CNS (particularly in the ventral horn of the spine, and various regions in the brain), heart, spleen, pancreas, and muscle tissue disease. 16, 61, 62, 66 However, due to its close relation to demyelinating viruses, 2,4,21-23 the error-prone RNA-dependent RNA polymerase (RdRp) replication method, 80 Therefore, studies into mechanisms of resistance for this RNA virus remain crucial yet unexplored. 80 Such understanding may allow us to be better prepared for viral resistance and thus develop therapeutic options targeted at critical mechanisms in viral replication. Reflecting on the recent Zika virus outbreaks, there are several lessons to be learnt. Strengthening research on lesser-known viruses such as SAFV (and related cardioviruses) is key to preventing public health catastrophes. 83 We hope SAFV will not mirror the course of Zika virus, but if it does, we need to be ready to halt progression before it reaches epidemic levels. Nucleotide sequence identifies Vilyuisk virus as a divergent Theiler's virus Saffold virus, a novel human cardiovirus with unknown pathogenicity Discovery of a novel human picornavirus in a stool sample from a pediatric patient presenting with fever of unknown origin Phylogenetic analysis of the species theilovirus: emerging murine and human pathogens New Saffold cardioviruses in 3 children Cardioviruses are genetically diverse and cause common enteric infections in South Asian children Saffold virus, a human Theiler'slike cardiovirus, is ubiquitous and causes infection early in life Cultivation and serological characterization of a human Theiler's-like cardiovirus associated with diarrheal disease Circulation of 3 lineages of a novel saffold cardiovirus in humans Full genomic characterization of a Saffold virus isolated in Peru Prevalence and genetic characteristics of Saffold cardiovirus in China from 2009 to 2012 Sequence and phylogenetic analyses of Saffold cardiovirus from children with exudative tonsillitis in Yamagata Isolation of Saffold virus type 2 in green monkey kidney cells Saffold virus is able to productively infect primate and rodent cell lines and induces apoptosis in these cells Adaptation of Saffold virus 2 for high-titer growth in mammalian cells The pathogenesis of Saffold virus in AG129 mice and the effects of its truncated L protein in the central nervous system Saffold virus infection in children Serious invasive saffold virus infections in children Genomic features and evolutionary constraints in Saffold-like cardioviruses Molecular mechanisms of translation initiation in eukaryotes Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability to infect cultured neurons Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination Apoptotic and antiapoptotic activity of L protein of Theiler's murine encephalomyelitis virus Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses The preparation of an infectious fulllength cDNA clone of Saffold virus Role(s) of leader protein of Saffold virus RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production Three cardiovirus Leader proteins equivalently inhibit four different nucleocytoplasmic trafficking pathways New Saffold cardiovirus in children Saffold cardiovirus in children with acute gastroenteritis Saffold cardioviruses of 3 lineages in children with respiratory tract infections Sequencing and phylogenetic analyses of Saffold cardiovirus (SAFV) genotype 3 isolates from children with upper respiratory infection in Gunma Molecular detection of Saffold Virus in children in Shanghai Saffold cardiovirus infection in children associated with respiratory disease and its similarity to coxsackievirus infection The impact of Saffold cardiovirus in patients with acute respiratory infections in Yamagata Saffold cardioviruses in children with diarrhea Co-circulation and persistence of genetically distinct saffold viruses Three clusters of Saffold viruses circulating in children with diarrhea in Japan Genetic diversity of circulating Saffold viruses in Pakistan and Afghanistan Saffold virus respiratory infection in children and immunocompromised patients in Spain Saffold viruses in pediatric patients with diarrhea in Thailand Molecular epidemiological analysis of Saffold cardiovirus genotype 3 from upper respiratory infection patients in Taiwan A newly designed real-time RT-PCR for SAFV detects SAFV-2 and SAFV-3 in the respiratory tracts of ill children during 2011 Isolation of Saffold virus type 2 from children with acute respiratory infections by using the RD-18S-niigata cell line Saffold virus infection associated with human myocarditis Seroepidemiology of Saffold cardiovirus (SAFV) genotype 3 in Japan Saffold cardiovirus infection in a 2-year-old boy with acute pancreatitis Acute pancreatitis with Kawasaki disease: analysis of cases with elevated serum amylase levels Mycoplasmal pneumonia treatment and management Enteroviruses The use of multiplex PCR for the diagnosis of viral severe acute respiratory infection in children: a high rate of co-detection during the winter season The IRIDICA BAC BSI assay: rapid, sensitive and culture-independent identification of bacteria and candida in blood Rapid diagnosis of infection in the critically Ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections Neuropathogenicity of two Saffold virus type 3 isolates in mouse models Neurotropism of Saffold virus in a mouse model Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors Two loci, TMEVP2 and TMEVp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system of mice Saffold cardiovirus and multiple sclerosis: no evidence for an association High frequency of coxsackie-Bvirus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset Isolation of a virus from the pancreas of a child with diabetic ketoacidosis Viral antibodies in diabetes mellitus Coxsackie-Bvirus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus Saffold virus, a human cardiovirus, and risk of persistent islet autoantibodies in the longitudinal birth cohort study MIDIA Theiler's virus infection of the mouse, or: of the importance of studying animal models Role of macrophages during Theiler's virus infection The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus Theiler's virus infection: a model for multiple sclerosis Infection of macrophages by Theiler's murine encephalomyelitis virus is highly dependent on their activation or differentiation state Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus Picornavirus RNA-dependent RNA polymerase Attenuation of human enterovirus 71 high replication fidelity variants in AG129 mice A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity Zika virus outbreak: 'a perfect storm Saffold virus, an emerging human cardiovirus The authors have no competing interest. This work was supported by Temasek Life Science Laboratory.